Tag: San Francisco
Biopharma VC Investing: Reporter’s JPM Notebook Insights
Biopharma VC Investing: Reporter's JPM Notebook InsightsSAN FRANCISCO — The J.P. Morgan Healthcare Conference isn’t just a venue for companies in the industry to...
Optimizing GLP-1 Drug Efficiency and Affordability in Virtual Care: JPM Week Highlights
Optimizing GLP-1 Drug Efficiency and Affordability in Virtual Care: JPM Week HighlightsThe J.P. Morgan Health Care conference in San Francisco this week was abuzz...
Alignment Healthcare Stays as Health Insurers Flee JPM
Alignment Healthcare Stands Strong Amidst Industry TurmoilIn the midst of the chaos at the J.P. Morgan Healthcare Conference, one company stands out - Alignment...
The Main Target and Focus: The article focuses on key figures attending the J.P....
Highlights from J.P. Morgan Healthcare Conference Day 2The J.P. Morgan Healthcare Conference on Day 2 saw a flurry of activity, with key industry figures...
Unveiling JPM Day 1: A Comprehensive Overview for Investors
Unveiling JPM Day 1: A Comprehensive Overview for InvestorsWelcome to STAT’s exclusive coverage of the much-anticipated “JPM Week” in San Francisco, where the biotech...
Navigating Pharma’s Patent Cliff: Impact on Obesity Fundraising and ALS Research
Navigating Pharma's Patent Cliff: Impact on Obesity Fundraising and ALS ResearchIn the fast-paced world of biotech, the looming patent cliff is causing a stir...
Biotech News Roundup: Stay Updated on the Latest Developments in the Industry
Good morning, everyone! Today, we have some interesting updates from the biotech industry. The BIOSECURE Act is facing a crucial moment as it needs...
Title: Analysis of Alector Therapeutics’ Alzheimer’s Treatment Failure in Phase 2 Study
Alector Therapeutics announced that their Phase 2 trial for a potential Alzheimer's antibody, known as AL002, was unsuccessful. This setback is disappointing as the...
Sutter Health CEO Donates to Harris in Wake of Antitrust Investigation
Sutter Health's CEO, Warner Thomas, recently made significant donations to Vice President Harris' presidential campaign and the Democratic National Committee. Despite Harris' involvement in...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
